PT87031A - Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith - Google Patents

Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith

Info

Publication number
PT87031A
PT87031A PT87031A PT8703188A PT87031A PT 87031 A PT87031 A PT 87031A PT 87031 A PT87031 A PT 87031A PT 8703188 A PT8703188 A PT 8703188A PT 87031 A PT87031 A PT 87031A
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
phenylpiperidine compounds
compositions therewith
therewith
Prior art date
Application number
PT87031A
Other languages
English (en)
Other versions
PT87031B (pt
Inventor
Frank Watjen
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of PT87031A publication Critical patent/PT87031A/pt
Publication of PT87031B publication Critical patent/PT87031B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT87031A 1987-03-31 1988-03-21 Processo de preparacao de compostos de 4-fenilpiperidina e de composicoes farmaceuticas que os contem PT87031B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK162087A DK162087D0 (da) 1987-03-31 1987-03-31 Piperidinforbindelser, deres fremstilling og anvendelse

Publications (2)

Publication Number Publication Date
PT87031A true PT87031A (pt) 1988-04-01
PT87031B PT87031B (pt) 1992-06-30

Family

ID=8106610

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87031A PT87031B (pt) 1987-03-31 1988-03-21 Processo de preparacao de compostos de 4-fenilpiperidina e de composicoes farmaceuticas que os contem

Country Status (12)

Country Link
US (1) US4845095A (pt)
EP (1) EP0285032A1 (pt)
JP (1) JPS63258456A (pt)
KR (1) KR880011098A (pt)
AU (1) AU1379488A (pt)
DK (1) DK162087D0 (pt)
FI (1) FI881410A7 (pt)
IL (1) IL85612A0 (pt)
NO (1) NO881388L (pt)
PH (1) PH24620A (pt)
PT (1) PT87031B (pt)
ZA (1) ZA881799B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE170174T1 (de) * 1994-01-13 1998-09-15 Merck Sharp & Dohme Gem-bissubstituierte azazyclische tachykinin- antagonisten
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
GB0510142D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds A1
US11976050B1 (en) 2023-10-11 2024-05-07 King Faisal University N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-1-naphthimidamide as an antimicrobial compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016170A (en) * 1975-07-28 1977-04-05 Sandoz, Inc. Oxadiazolyl benzamides

Also Published As

Publication number Publication date
IL85612A0 (en) 1988-08-31
PH24620A (en) 1990-08-17
ZA881799B (en) 1988-09-05
PT87031B (pt) 1992-06-30
FI881410A7 (fi) 1988-10-01
JPS63258456A (ja) 1988-10-25
EP0285032A1 (en) 1988-10-05
KR880011098A (ko) 1988-10-26
AU1379488A (en) 1988-09-29
FI881410A0 (fi) 1988-03-24
NO881388L (no) 1988-10-03
NO881388D0 (no) 1988-03-29
US4845095A (en) 1989-07-04
DK162087D0 (da) 1987-03-31

Similar Documents

Publication Publication Date Title
PT87474A (pt) Process for the preparation of pharmaceutical compounds which contain ester 1-acetoxi-ethylic of cefuroxime
FI882369A7 (fi) Menetelmä lääkeaineena käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
NO174239C (no) Fremgangsmåte for fremstilling av et oralt, farmasöytisk preparat
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
FI874459A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
PT87470A (pt) Process for the preparation of novel substituted benzamides and of pharmaceutical compositions containing the same
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
FI886057L (fi) Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksi
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
PT87503A (pt) Process for the preparation of new cathecolamine by products
PT86874A (pt) Process for the preparation of cromona by products and of pharmaceutical compounds containing them
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
PT86776A (pt) Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it
PT87031A (pt) Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith
PT87679A (pt) A process for the preparation of 2-methoxymethyl-penem derivatives and of pharmaceutical compositions containing the same
PT87643A (pt) Process for the preparation of pyran compounds
PT84184A (pt) Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
PT87359A (pt) Process for the preparation of pyrrolidine derivatives
FI891191A7 (fi) Menetelmä 3-eksometyleeni-kefam-johdannaisten valmistamiseksi
MX11584A (es) Composiciones farmaceuticas

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911213

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19930630